Literature DB >> 32423949

Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence.

Inga Fröding1,2, Badrul Hasan3,4, Isak Sylvin2,5, Maarten Coorens3,2, Pontus Nauclér6,7, Christian G Giske3,2.   

Abstract

Invasive infections due to extended-spectrum-β-lactamase- and pAmpC-producing Escherichia coli (ESBL/pAmpC-EC) are an important cause of morbidity, often caused by the high-risk clone sequence type (ST131) and isolates classified as extraintestinal pathogenic E. coli (ExPEC). The relative influence of host immunocompetence versus microbiological virulence factors in the acquisition and outcome of bloodstream infections (BSI) is poorly understood. Herein, we used whole-genome sequencing on 278 blood culture isolates of ESBL/pAmpC-EC from 260 patients with community-onset BSI collected from 2012 to 2015 in Stockholm to study the association of virulence genes, sequence types, and antimicrobial resistance with severity of disease, infection source, ESBL/pAmpC-EC BSI low-risk patients, and patients with repeated episodes. ST131 subclade C2 comprised 29% of all patients. Factors associated with septic shock in multivariable analysis were patient host factors (hematologic cancer or transplantation and reduced daily living activity), presence of the E. coli virulence factor iss (increased serum survival), absence of phenotypic multidrug resistance, and absence of the genes pap and hsp Adhesins, particularly pap, were associated with urinary tract infection (UTI) source, while isolates from post-prostate biopsy sepsis had a low overall number of virulence operons, including adhesins, and commonly belonged to ST131 clades A, B, and subclade C1, ST1193, and ST648. ST131 was associated with recurrent episodes. In conclusion, the most interesting finding is the association of iss with septic shock. Adhesins are important for UTI pathogenesis, while otherwise low-pathogenic isolates from the microbiota can cause post-prostate biopsy sepsis.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  ESBL; Escherichia coli; WGS; bacteremia; medical outcomes; mortality; virulence factors

Mesh:

Substances:

Year:  2020        PMID: 32423949      PMCID: PMC7526827          DOI: 10.1128/AAC.02351-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study.

Authors:  Sofia Ny; Sonja Löfmark; Stefan Börjesson; Stina Englund; Maj Ringman; Jakob Bergström; Pontus Nauclér; Christian G Giske; Sara Byfors
Journal:  J Antimicrob Chemother       Date:  2016-10-24       Impact factor: 5.790

2.  Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy.

Authors:  Deborah A Williamson; Joshua T Freeman; Stephen Porter; Sally Roberts; Siouxsie Wiles; David L Paterson; James R Johnson
Journal:  J Antimicrob Chemother       Date:  2013-07-05       Impact factor: 5.790

3.  Escherichia coli isolates from patients with bacteremic urinary tract infection are genetically distinct from those derived from sepsis following prostate transrectal biopsy.

Authors:  Michael Dan; Yael Yair; Alex Samosav; Tamar Gottesman; Orit Yossepowitch; Orna Harari-Schwartz; Alexander Tsivian; Rachel Schreiber; Uri Gophna
Journal:  Int J Med Microbiol       Date:  2015-04-25       Impact factor: 3.473

4.  Rapid Identification of Different Escherichia coli Sequence Type 131 Clades.

Authors:  Yasufumi Matsumura; Johann D D Pitout; Gisele Peirano; Rebekah DeVinney; Taro Noguchi; Masaki Yamamoto; Ryota Gomi; Tomonari Matsuda; Satoshi Nakano; Miki Nagao; Michio Tanaka; Satoshi Ichiyama
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Recombinant Iss as a potential vaccine for avian colibacillosis.

Authors:  Aaron M Lynne; Subhashinie Kariyawasam; Yvonne Wannemuehler; Timothy J Johnson; Sara J Johnson; Avanti S Sinha; Dorie K Lynne; Harley W Moon; Dianna M Jordan; Catherine M Logue; Steven L Foley; Lisa K Nolan
Journal:  Avian Dis       Date:  2012-03       Impact factor: 1.577

Review 6.  Resistance to serum complement, iss, and virulence of avian Escherichia coli.

Authors:  L K Nolan; S M Horne; C W Giddings; S L Foley; T J Johnson; A M Lynne; J Skyberg
Journal:  Vet Res Commun       Date:  2003-02       Impact factor: 2.459

Review 7.  Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli.

Authors:  James R Johnson; Thomas A Russo
Journal:  Int J Med Microbiol       Date:  2005-10       Impact factor: 3.473

8.  Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract.

Authors:  Rachel R Spurbeck; Paul C Dinh; Seth T Walk; Ann E Stapleton; Thomas M Hooton; Lisa K Nolan; Kwang Sik Kim; James R Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

9.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2014-01-21       Impact factor: 6.937

Review 10.  A genomic overview of the population structure of Salmonella.

Authors:  Nabil-Fareed Alikhan; Zhemin Zhou; Martin J Sergeant; Mark Achtman
Journal:  PLoS Genet       Date:  2018-04-05       Impact factor: 5.917

View more
  7 in total

Review 1.  Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.

Authors:  Johann D D Pitout; Gisele Peirano; Liang Chen; Rebekah DeVinney; Yasufumi Matsumura
Journal:  Antimicrob Agents Chemother       Date:  2022-06-06       Impact factor: 5.938

2.  The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative study.

Authors:  Anna Lindblom; Camilla Kiszakiewicz; Erik Kristiansson; Shora Yazdanshenas; Nina Kamenska; Nahid Karami; Christina Åhrén
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

3.  Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain.

Authors:  Javier Fernández; Azucena Mora; Isidro García-Meniño; Pilar Lumbreras; Luz Lestón; Mónica Álvarez-Álvarez; Vanesa García; Jens Andre Hammerl
Journal:  Microbiol Spectr       Date:  2022-05-23

4.  Molecular Epidemiology and Presence of Hybrid Pathogenic Escherichia coli among Isolates from Community-Acquired Urinary Tract Infection.

Authors:  Júllia A S Nascimento; Fernanda F Santos; José F Santos-Neto; Liana O Trovão; Tiago B Valiatti; Isabel C Pinaffi; Mônica A M Vieira; Rosa M Silva; Ivan N Falsetti; Ana C M Santos; Tânia A T Gomes
Journal:  Microorganisms       Date:  2022-01-27

Review 5.  Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.

Authors:  Huanna Tang; Hui Zhou; Runju Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073

6.  Convergence of virulence and antimicrobial resistance in increasingly prevalent Escherichia coli ST131 papGII+ sublineages.

Authors:  Michael Biggel; Pieter Moons; Minh Ngoc Nguyen; Herman Goossens; Sandra Van Puyvelde
Journal:  Commun Biol       Date:  2022-07-28

Review 7.  NGSocomial Infections: High-Resolution Views of Hospital-Acquired Infections Through Genomic Epidemiology.

Authors:  Alexander L Greninger; Danielle M Zerr
Journal:  J Pediatric Infect Dis Soc       Date:  2021-12-24       Impact factor: 3.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.